Gennecs
Our Team
Gennecs
Our Team
Gennecs / Gennvax
Management Team
Adam El Daba Founder & CEO
Gennecs Pharmaceutical / Gennvax
Adam Eldaba is a prominent entrepreneur with extensive experience in establishing, growing, and selling businesses across various sectors. He is the Founder and CEO of Gennecs Pharmaceuticals, the pharmaceutical arm of Eldaba Holding Group, and the main sponsor and investor of Gennvax, the company’s vaccine development division.
With his entrepreneurial acumen, Adam has successfully founded, scaled, and exited multiple businesses in industries such as real estate, F&B, IT, trading, and healthcare.
Additionally, he has invested in over 18 companies across 5 countries, demonstrating his deep understanding of diverse industries and his ability to identify promising opportunities for investment and growth.
Adam’s leadership skills and expertise have made him a notable figure in the business world, and his work with Gennecs Pharmaceuticals and Gennvax have established them as major players in the healthcare industry.
Nibal Dahaba, General Manager
Gennecs Pharmaceutical / Gennvax
Nibal Dahaba is a dynamic leader with extensive experience in the pharmaceutical industry. As the General Manager of Gennecs Holding/Gennvax, Nibal has continued to demonstrate her passion for making a difference in healthcare.
She previously served as the Head of Sanofi Pasteur (Egypt & Africa), where she launched the business across the continent and made a significant impact on the National Immunization Program (NIP) in Africa. With a strong track record of success, Nibal has also held executive positions at global pharmaceutical giants such as Merck, Abbvie, and Novartis.
Her impressive achievements include sealing deals with UNICEF, WHO, and several African governments. Nibal was also instrumental in rolling out the Virus C treatment supply across Egypt as the main liaison between the Egyptian and U.S governments. Nibal Dahaba’s leadership and expertise have made her a driving force in the pharmaceutical industry.
Richard Van Duyse, Project Manager
Gennvax project Lead
Richard is an experienced professional in the medical field specializing in the creation and
Richard is an experienced professional in the medical field specializing in the creation and
establishment of new vaccine manufacturing facilities. Dr. Richard worked with Tianyuan (now known as GSK company) and Biovac Institute to establish their facilities in China and South Africa. He previously also worked with CDC Africa and served as UNIDO Member and Consultant.
Steve Biddulph, Head of Quality Assurance & Quality Control
Gennvax
Steve is a microbiologist with more than 50 years’ experience in the pharmaceutical and biopharmaceutical industries. He has held senior positions in Quality with leading multinational companies, Fisons, RPR, Aventis and Pasteur, initially at manufacturing site level and later in corporate roles, where, in recent years, he has held global responsibilities for all quality compliance activities and teams, as Vice-President Worldwide Quality for Aventis/Sanofi Pasteur.
Harry Biddulph, Documentation Systems, IT hardware & software
Gennvax
Hary is an IT and Business Intelligence specialist who has worked with Sanofi Pasteur and Galenisys in both of these roles, Hary is experienced in the design and use of web sites, social media, IT systems and documentation systems. He is adept at identifying and using rare examples of software to perform his tasks.
Adam Slatter, QMS, Regulatory Compliance, Vaccine manufacture & control
Gennvax
Adam is a seasoned, high level industry professional who has unparalleled expertise in sterile product manufacture and control, Contamination prevention & Control, Sterility Assurance, Microbiology QC, Quality Systems and Compliance with the regulatory requirements of agencies worldwide but particularly with the FDA, EMA, Health Canada, WHO and TGA.
Terry Simmons, Technical Director , Supply chain, sterile product manufacture, QMS
Gennvax
Terry is an analytical chemist who has 30 years experience in the life science industries – pharmaceuticals, biologics, medical devices and cosmetics. Terry has held many positions in Manufacturing Operations, Quality, Quality Control, Supply chain and, latterly, as the Director in charge of a major manufacturing site He is very experienced with the EMA, WHO and FDA and has successfully participated in many regulatory and third-party inspections/audits including preparation, inspection management and in the definition and implementation of corrective action plans for both FDA and EMA.
Jean Jacques Richard, Vaccine manufacture and control, QC, Regulatory Compliance
Gennvax
Jean-Jacques is an experienced Health Industry professional who has held positions in both manufacturing and quality. He has wide experience in managing and organizing both Quality and Manufacturing teams and in developing their skills and competencies. Jean-Jacques worked in many areas of the Health Industry including Pharmaceuticals, Vaccines and Biologics.He had a remarkable era with Sanofi Pasteur serving as Industrial Affairs VP of in Asia and Quality Control Global VP. He has also held multiple positions with GSK and Shanta Technics.
José Zapata, Senior Associate GennVax
Gennvax
Jose is a member of the Pan American Health Organization as well as being a Senior Consultant for CEPI.
Jose has extensive experience in research, production, quality control and technology access of vaccines, having reviewed and published in multiple journals.
Syed Ahmed
Gennvax
Syed has extensive experience in greenfield vaccine projects. He was appointed as a Project Head of South Africa vaccine facility and was also the Project Head of the Nicaragua/St. Petersburg vaccine facility.
Currently Syed is the CEO of TechInvention Life Care for vaccines R&D and a Member of the Institute of Technology and Management.
